Abstract:BACKGROUND: At present, non-viral vectors have become a hotspot in gene transfection research because of their strong points of lower toxicity,low immunologic reaction, target orientation, and easy assembly.OBJECTIVE: To evaluate the role of chitosan-DNA nanoparticles in transfection efficiency and cellular toxicity of tumor cells.DESIGN: Observational control trial. SETTING: Institute of Environmental Medical Sciences, Tongji Medical College of Huazhong University of Science and Technology.MATERIALS: Zeta potential/ particle size analyzer; spectrofluorometer;Hoechst 33258; PLPS-3'EGFP plasmid; lung cancer cell A549 and human hepatocarcinoma cell line HepG2.METHODS: This experiment was conducted in the Institute of Environmental Medical Sciences, Tongji Medical College of Huazhong University of Science and Technology, from December 2004 to December 2005. The green fluorescent protein gene was used as report gene; chitosan green fluorescent protein plasmid nanoparticles were prepared with re-coherence gy of prepared nanoparticles; Zeta potential/ particle size analyzer was used to measure the diameter and superficial potential of the nanoparticles;enzyme-protection test was used to measure anti DNA enzyme degradation and lung cancer cell A549 were transfected in vitro. Transfection of the cells was observed under the inverted fluorescence microscope after 24, 48nanoparticles.characteristics: Nucleic acid encapsulation efficiency of chitosan nanoparticles was 91.7%, and the nanoparticles presented globular shape with the mean diameter of 149nm and superficial potential of +20.5 mV.Transfection rate of nanoparticles: It reached the peak 48 hours later; the transfection rate of A549 was 95% while that of HepG2 was only about chitosan could inhibit the growth of HepG2 and A549, and the inhibitory effect of chitosan on cellular growth was stronger than that of the nanoparticles.CONCLUSION: Nanoparticles of chitosan plasmid can transfect HepG2and A549, two kinds of tumor cells, and have inhibitory effects on their growth, suggesting that nanoparticles, as the carrier of DNA, can be used in the transfection of tumor cells.

Uptake of oleoyl-chitosan nanoparticles by A549 cells.

[Study of the Uptake of Chitosan Oligosaccharide Nanoparticles by A549 Cells].

[Uptake of Monostearin Solid Lipid Nanoparticles by A549 Cells].

Preparation and characterization of fluorimetric folate-coupled chitosan nano-carrier

Folate Receptor Mediated Intracellular Gene Delivery Using the Charge Changing Solid Lipid Nanoparticles.

Self-assembled Polymeric Nanoparticles Based on Oleic Acid-Grafted Chitosan Oligosaccharide: Biocompatibility, Protein Adsorption and Cellular Uptake

Preparation and characterization of self-assembled nanoparticles of 6-O-cholesterol-modified chitosan for drug delivery

Tracing transport of chitosan nanoparticles and molecules in Caco-2 cells by fluorescent labeling

Cellular Uptake and Transport Characteristics of Chitosan Modified Nanoparticles in Caco-2 Cell Monolayers.

Biocompatibility, Cellular Uptake and Biodistribution of the Polymeric Amphiphilic Nanoparticles As Oral Drug Carriers.

Preparation and Characterization of Folate Conjugated N-trimethyl Chitosan Nanoparticles As Protein Carrier Targeting Folate Receptor: in Vitro Studies.

Uptake of cerium oxide nanoparticles and their influences on functions of A549 cells.

Investigating the Effect of Particle Size on Cellular Uptake by Aggregation-Caused Quenching Probe–Encapsulating Solid Lipid Nanoparticles, Inhaled

Preparation and research of affinity of N-octyl-N′-succinyl chitosan for four kinds of tumor cells

Tat Peptide Mediated Cellular Uptake of SiO2 Submicron Particles.

Nebulized Anionic Guanidinylated O-carboxymethyl Chitosan/n-2-hydroxypropyltimehyl Ammonium Chloride Chitosan Nanoparticles for Sirna Pulmonary Delivery: Preparation, Characterization and in Vitro Evaluation

Synthesis and Characterization of Folate-Poly(Ethylene Glycol) Chitosan Graft-Polyethylenimine As A Non-Viral Carrier for Tumor-Targeted Gene Delivery

Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study.

Both FA- and Mpeg-Conjugated Chitosan Nanoparticles for Targeted Cellular Uptake and Enhanced Tumor Tissue Distribution

Study on Intracellular Pathway of Pdna/chitosan Nanoparticles for Gene Delivery by Fluorescence Probe

Transfection Efficiency of Chitosan-Dna Nanoparticles on Tumor Cells